Co-detection by two imidazoline receptor protein antisera of a novel 85 kilodalton protein

Biochemical Pharmacology

Volumn 55, Issue 5, 1998, Pages 649-655

  Ivanov, Tina R ^a   Zhu, He ^a   Regunathan, Soundararajan ^b   Reis, Donald J ^b   Dontenwill, Monique ^c   Vonthron, Catherine ^c   Bousquet, Pascal ^c   Piletz, John E ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c CNRS   (France)

Author keywords

Antibody; Human cortex; Imidazoline receptors; Monoamine oxidase; PC12 cells; Protease inhibitors; Rat brain

Indexed keywords

IMIDAZOLINE RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL STRAIN; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MOLECULAR WEIGHT; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; THROMBOCYTE;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; BRAIN; HUMANS; IMMUNE SERA; MALE; PC12 CELLS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG;

EID: 0032031408     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00537-6     Document Type: Article

References (31)

1. 1. Bousquet P, Feldman J and Schwartz J, Central cardiovascular effects of α adrenergic drugs; differences between catecholamines and imidazolines. J Pharmacol Exp Ther 230: 232-236, 1984.
2. 2. Michel MC and Ernsberger P, Keeping an eye on the I site: Imidazoline-preferring receptors. Trends Pharmacol Sci 13: 369-370, 1992.
3. 1-imidazoline receptors: Definition, characterization, distribution, and transmembrane signaling. Ann NY Acad Sci 763: 22-42, 1995.
4. 4. Rupp H and Jacob R, Excess catecholamines and the metabolic syndrome: Should central imidazoline receptors be a therapeutic target? Med Hypotheses 44: 217-225, 1995.
5. 2-adrenergic receptors: Implications for depression. Crit Rev Neurobiol 9: 29-66, 1995.
6. 1-imidazoline receptors in PC12 cells and rostral ventrolateral medulla. Brain Res 749: 335-339, 1997.
7. 2 imidazoline binding sites on monoamine oxidases. J Biol Chem 270: 9856-9861, 1995.
8. 8. Lanier B, Raddatz R, Bakthavachalam V, Coupry I, Neumeyer JL and Lanier SM, Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit. Mol Pharmacol 48: 703-710, 1995.
9. 9. Regunathan S and Reis DJ, Imidazoline receptors and their endogenous ligands. Annu Rev Pharmacol Toxicol 36: 511-544, 1996.
10. 10. Wang H, Regunathan S, Meeley MP and Reis DJ, Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin cells. Mol Pharmacol 42: 792-801, 1992.
11. 11. Wang H, Regunathan S, Ruggiero DA and Reis DJ, Production and characterization of antibodies specific for the imidazoline receptor protein. Mol Pharmacol 43: 509-515, 1993.
12. 12. Escribá PV, Sastre M, Wang H, Regunathan S, Reis DJ and García-Sevilla JA, Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues. Neurosci Lett 178: 81-84, 1994.
13. 3H]-idazoxan binding sites. Br J Pharmacol 118: 2029-2036, 1996.
14. 2 imidazoline-preferring receptors. Br J Pharmacol 114: 837-845, 1995.
15. 15. Bennai F, Greney H, Molines A, Bousquet P, and Dontenwill M, Antiidiotypic antibodies as tools to study imidazoline receptors. Ann NY Acad Sci 763: 140-148, 1995.
16. 16. Bennai F, Greney H, Vonthron C, Bousquet P and Dontenwill M, Polyclonal anti-idiotypic antibodies to idazoxan and their interaction with human brain imidazoline binding sites. Eur J Pharmacol 306: 211-218, 1996.
17. 17. Greney H, Bennai F, Molines A, Belcourt A, Dontenwill M and Bousquet P, Isolation of a human cerebral imidazoline-specific binding protein. Eur J Pharmacol 265: R1-R2, 1994.
18. 3H]clonidine. Neurochem Int 25: 183-191, 1994.
19. 19. Escribá PV, Ozaita A, Miralles A, Reis DJ and García-Sevilla JA, Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain. Mol Brain Res 32: 187-196, 1995.
20. 20. García-Sevilla JA, Escribá PV, Sastre M, Walzer C, Busquets X, Jaquet G, Reis DJ and Guimon J, Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch Gen Psychiat 53: 803-810, 1996.
21. 21. Greene LA and Tischler AS, Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73: 2424-2428, 1976.
22. 3H]DOPA in various regions of the brain. J Neurochem 13: 655-669, 1966.
23. 23. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 221: 680-685, 1970.
24. 3H]idazoxan. Neurosci Lett 184: 133-136, 1995.
25. 2adrenoceptors in the human central nervous system. Neuroscience 59: 589-598, 1994.
26. 2-adrenoceptors and imidazoline binding sites: Distribution of imidazoline binding sites in rat brain. Brain Res 514: 15-21, 1990.
27. 3H]rilmenidine. Brain Res 675: 264-278, 1995.
28. 3H]idazoxan label different populations of imidazoline sites on rat kidney. Eur J Pharmacol 232: 79-87, 1993.
29. 29. Ruggiero DA, Regunathan S, Wang H, Milner TA and Reis DJ, Distribution of imidazoline receptor binding protein in the central nervous system. Ann NY Acad Sci 763: 208-221, 1995.
30. 1-imidazoline sites. Ann NY Acad Sci 763: 163-168, 1995.
31. 31. Scheeler P, Centrifugation in Biology and Medicine. Wiley Press, New York, 1981. Biochemical Pharmacology, Vol. 55, pp. 667-676, 1998.